Isoptin 120 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

isoptin 120 mg filmom obložene tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - verapamilklorid - filmom obložena tableta - 120 mg - urbroj: jedna filmom obložena tableta sadrži 120 mg verapamilklorida

Isoptin 40 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

isoptin 40 mg filmom obložene tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - verapamilklorid - filmom obložena tableta - 40 mg - urbroj: jedna filmom obložena tableta sadrži 40 mg verapamilklorida

Isoptin 5 mg/2 ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

isoptin 5 mg/2 ml otopina za injekciju

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - verapamilum - otopina za injekciju - 5 mg/2 ml - urbroj: 1 ml otopine za injekciju sadrži 2,5 mg verapamilklorida

Isoptin 80 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

isoptin 80 mg filmom obložene tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - verapamilklorid - filmom obložena tableta - 80 mg - urbroj: jedna filmom obložena tableta sadrži 80 mg verapamilklorida

Isoptin RR 240 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

isoptin rr 240 mg tablete s produljenim oslobađanjem

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - verapamilklorid - tableta s produljenim oslobađanjem - 240 mg - urbroj: jedna tableta s produljenim oslobađanjem sadrži 240 mg verapamilklorida

Vildagliptin / Metformin hydrochloride Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Sitagliptin / Metformin hydrochloride Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.